Replies to post #77948 on Ayala Pharmaceuticals Inc (fka ADXS)

[cdiddy01]

one scenario could be selling 20Mish shares at somewhere between $1 and $1.50 and netting somewhere between $20M - $30M cash

You would get nowhere near that. You'd have to take a massive discount and include all the banking fee's etc for the issuance..

If AXAL/Cervical is wound-down, Ken should be able to get annual burn-rate down closer to $35M

Pretty sure his cut to 50$ million a year was already predicated on that notion. Not saying he couldn't find more fat to trim, but how much?

ADXS would still only have 70M shares outstanding in above scenario

That would put us closer to 80+ million shares for peanuts (fully diluted and minus the warrants).

All that said, PSA HOT deal with Merck could come first later this year or early 2019, before any capital raising.

This is what all of us our hoping for... Any deal that is reasonable. We're going on years now and we still haven't been able to secure a strong deal for AXAL. I'm still hopeful though...